Xtant medical holdings, inc. (XTNT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue
Orthopedic product sales

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Orthopedic product sales

-

-

65,766

67,214

-

71,814

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other revenue

169

166

214

311

325

389

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Revenue

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Revenue

-

-

65,980

67,525

-

72,203

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Orthopedic product sales

-

-

-

-

-

-

-

-

-

-

-

-

90,576

89,388

86,789

81,303

69,725

58,194

45,287

36,112

35,094

34,569

33,846

33,310

32,791

32,563

32,416

33,349

33,266

32,414

31,664

30,391

0

-

0

0

-

-

-

Other revenue

-

-

-

-

-

-

-

-

-

-

-

-

532

614

1,000

1,085

1,094

1,151

864

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalties and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

674

575

509

521

537

562

565

349

415

459

492

719

432

0

0

0

Total Revenue

-

-

-

-

-

-

-

-

-

-

-

-

91,108

90,002

87,790

82,388

70,819

59,345

46,170

36,930

35,921

35,331

34,508

33,984

33,367

33,073

32,937

33,887

33,828

32,979

34,090

32,750

32,050

30,149

24,962

20,608

0

0

0

Cost of sales

21,418

22,166

27,533

28,027

28,928

28,717

26,750

29,423

31,037

32,511

30,432

29,130

28,008

27,710

28,128

27,050

23,667

20,262

16,198

13,180

13,096

13,034

13,892

14,193

14,475

14,185

13,560

12,842

11,599

10,337

8,107

7,248

0

-

0

0

-

-

-

Cost of tissue and medical devices sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gross Profit

41,316

42,516

38,447

39,498

42,067

43,486

46,523

46,373

47,426

50,101

57,317

61,924

63,099

62,292

59,661

55,338

47,152

39,082

29,971

23,749

22,825

22,297

20,615

19,791

18,891

18,887

19,377

21,044

22,229

22,642

22,108

22,050

21,938

21,040

20,481

16,942

0

0

0

Operating Expenses
General and administrative

17,778

17,936

17,306

16,272

15,729

14,277

12,905

13,114

14,143

15,246

16,590

17,033

16,405

15,762

15,345

15,552

14,052

12,993

11,027

9,328

9,023

8,886

9,484

9,928

9,921

10,204

11,170

10,882

11,116

11,135

8,238

7,948

7,134

6,935

8,175

7,966

0

0

0

Sales and marketing

25,514

25,843

26,219

27,384

29,857

31,464

34,214

35,271

37,863

40,511

42,917

45,256

44,539

44,055

42,727

39,914

34,530

28,731

22,704

18,201

17,571

16,912

16,347

16,473

16,274

16,017

16,340

15,639

15,269

15,617

16,430

17,887

18,383

18,501

15,725

12,599

0

0

0

Research and development

915

932

1,198

1,342

1,550

1,702

1,777

1,934

2,156

2,441

2,641

3,066

3,210

3,410

3,639

3,505

3,012

2,546

2,007

1,590

1,621

1,443

1,034

694

541

572

0

0

0

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

1,486

2,378

-

-

4,454

4,779

5,208

5,485

5,355

5,266

5,013

4,940

5,744

6,019

4,903

3,819

1,821

338

320

271

289

328

346

377

409

399

394

406

447

478

445

379

399

0

0

0

-

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of goodwill and intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition and integration related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

1,401

5,126

0

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring expenses

-

-

-

-

-

2,970

4,435

5,015

5,413

4,680

2,826

1,632

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Separation related expenses

-

-

-

-

-

-

-

-

-

1,901

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition and integration related expenses (Note 2)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash compensation expense

-

-

-

-

-

-

-

-

304

85

0

0

0

-

-

215

234

246

244

233

181

135

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-51

92

69

427

1,199

1,160

0

-

0

0

-

-

-

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,199

1,160

0

-

0

0

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash consulting expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Total Operating Expenses

44,265

44,769

95,108

96,889

101,156

103,564

76,107

79,207

84,350

87,935

72,076

73,902

70,849

69,837

70,127

68,785

59,860

51,161

40,462

30,606

29,631

28,562

27,949

28,222

27,857

27,895

28,361

27,469

27,134

27,587

26,185

27,905

27,725

27,490

26,348

22,521

0

0

0

Loss from Operations

-2,949

-2,253

-56,661

-57,391

-59,089

-60,078

-29,584

-32,834

-36,924

-37,834

-14,759

-11,978

-7,749

-7,545

-10,466

-13,447

-12,708

-12,078

-10,491

-6,856

-6,805

-6,264

-7,334

-8,431

-8,966

-9,007

-8,984

-6,424

-4,904

-4,944

-4,076

-5,854

-5,787

-6,450

-5,867

-5,578

0

0

0

Other (Expense) Income
Interest expense

4,862

5,772

6,494

7,099

8,618

10,145

12,323

14,342

14,850

14,705

13,824

13,179

12,835

12,262

11,777

10,725

9,125

7,733

6,375

5,761

5,820

5,660

5,433

5,132

4,864

4,653

3,996

3,666

2,758

1,864

1,420

1,094

960

1,162

1,206

1,447

0

0

0

Change in warrant derivative liability

24

3

31

69

144

121

150

88

-5

203

136

376

868

716

1,065

1,242

750

270

618

1,874

2,759

1,736

1,666

-835

-1,246

875

213

936

1,777

1,360

299

670

-623

6,377

739

502

0

0

0

Non-cash consideration associated with stock purchase agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

558

558

558

558

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other (expense) income

-31

-101

-117

-117

-59

3

-69

-99

-100

-75

-29

-81

85

-351

271

232

-48

388

-257

-238

-120

-318

-270

-182

-87

92

66

-1,689

-1,745

-1,558

-691

-255

-298

-471

0

0

0

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total Other (Expense)

-4,869

-5,870

-6,579

-7,146

-8,533

-10,021

-12,243

-14,354

-14,955

-14,577

-13,718

-12,884

-11,882

-11,897

-10,440

-9,250

-8,423

-7,633

-6,572

-4,683

-3,739

-4,243

-4,036

-6,150

-6,197

-3,685

-4,422

-5,125

-3,431

-2,769

-3,113

-1,979

-3,182

3,443

-1,828

-1,004

0

0

0

Net Loss Before Provision for Income Taxes

-7,818

-8,123

-63,240

-64,537

-67,622

-70,099

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,713

-5,999

-3,885

0

-

0

0

-

-

-

Provision for Income Taxes
Net Loss Before (Provision) Benefit for Income Taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

Deferred

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

Provision for income taxes

-99

-98

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-7,915

-8,221

-63,308

-64,582

-67,645

-70,099

-41,827

-47,188

-51,879

-52,411

-28,528

-24,912

-19,682

-19,493

-3,369

-5,160

-3,593

-2,174

-17,063

-11,539

-10,544

-10,507

-11,370

-14,581

-15,164

-12,693

-13,407

-11,549

-8,336

-7,713

-7,189

-7,834

-8,970

-3,006

-7,696

-6,582

0

0

0

Net loss per share:
Basic

-0.19

-0.13

-0.14

-0.15

-0.21

-4.65

-0.24

-0.38

-0.70

-18.84

-5.62

-6.43

-3.87

-17.22

-0.40

-0.37

-0.47

1.43

-0.64

-0.41

-0.62

-0.45

-0.19

-0.35

-0.77

-1.36

-0.85

-0.55

-0.04

-0.11

-0.06

0.02

-0.03

-0.12

-0.08

-0.01

0.13

-0.26

-0.07

Dilutive

-0.19

-0.13

-0.14

-0.15

-0.21

-4.65

-0.24

-0.38

-0.70

-18.84

-5.62

-6.43

-3.87

-17.22

-0.40

-0.37

-0.47

1.43

-0.64

-0.41

-0.62

-0.45

-0.19

-0.35

-0.77

-1.36

-0.85

-0.55

-0.04

-0.11

-0.06

0.02

-0.03

-0.10

-0.08

-0.01

0.11

-0.26

-0.07

Shares used in the computation:
Basic

13,175

13,161

13,161

13,161

13,170

13,236

13,158

13,085

7,481

1,514

1,514

1,507

1,494

-31,969

12,193

12,101

11,897

11,962

10,432

7,137

6,689

6,688

6,233

5,514

5,379

-34,492

5,161

4,525

42,926

42,741

42,796

42,695

41,548

40,654

39,574

38,216

37,330

35,398

28,318

Dilutive

13,175

13,161

13,161

13,161

13,170

13,236

13,158

13,085

7,481

1,514

1,514

1,507

1,494

-31,969

12,193

12,101

11,897

11,962

10,432

7,137

6,689

6,688

6,233

5,514

5,379

-34,492

5,161

4,525

42,926

40,753

42,796

44,683

41,548

33,565

39,574

38,216

44,419

35,398

28,318